University of Ioannina
Ο ρόλος της αναστολής των βασικών ενζύμων της αραχιδονικής οδού COX-1, COX-2 και LOX μέσω ενός συμπλόκου του κασσιτέρου με ναπροξένη στον θάνατο και την βιωσιμότητσ σειρών νεοπλασματικών και φυσιολογικών κυττάρων, όπως επίσης και σε καρκινοπαθή πειραματόζωα
Abstract
dc:descriptionThe role of inhibition of the basic enzymes of arachidonate pathway COX-1, COX-2 and LOX through a complex of tin and Naproxen in death and series viability of neoplastic and normal cells, as well as in animals suffering from cancer»Anti-inflammatory drugs, according to new research can be also used as anticancer drugs. It was found that they enhance the mechanism of apoptosis and inhibit angiogenesis. Most of the times, nonsteroidal antiinflammatory drugs inhibit the basic enzymes selectively-products of the metabolism of arachidonic acid-cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and lipoxygenase (LOX). These enzymes are expressed in most tissues with suitable agitation, such as inflammation, pain, immunological response and tumorigenesis. Naproxen is a non-steroidal anti-inflammatory drug which is a mixed inhibitor of both COX-1 and COX-2. The antiinflammatory action of Naproxen is twenty times greater than that of aspirin. Cancer is associated with inflammation, as epidemiological data show that connection since a long inflammation leads to dysplasia.In this thesis, we studied the inhibition of basic enzymes involved in arachidonic metabolism and the role of such suspension in sustainability and mortality of cancer cell series but also that of normal ones, as well as in experiments in vivo. For this purpose, the composition and the characterization of a complex with tin and ligand, known as inflammatory Naproxen [Bu2Sn (naproxen)2], was legimate.The in vitro experiments showed that the Bu2Sn(naproxen)2 presented strong cytotoxic activity in four cancer cell lines (LMS, MCF-7, HeLa, U20S), where the concentration value of IC50 is in the order of mM. And it was tested in normal cell line (MRC-5) with the smallest effect. The complex appears to induce cell death via the mechanism of apoptosis and to inhibit colony forming ability. Also, it causes of great inhibition on platelet accumulation via the route of ADP and PAF. When mixed with antioxidants it showed ability to protect against the lethal effects of the complex even at lower concentrations, as antioxidant factors, preventing the toxic effects of the complex. It inhibits twice more than Naproxen enzymes COX-1 and COX-2 and five times more than the enzyme LOX.In vivo experiments the complex showed no toxic effects after single administration. It only showed pulmonary edema in chronic toxicity in the greatest dose administered. The activity of the complex is also evident during the pathologic inspection in which tumor necrosis appears after the administration of the complex in an amount of 80-100%. No metastatic foci was apparent. In Wistar rats suffering from cancer increased the survival time up to 150%.In conclusion we would say that it is likely that through inhibition of the basic enzymes of arachidonate pathway completely blocking the formation of the tumor, to be completely blocked and if the complex is used as an anticancer drug, it can lead to the complete tumor necrosis without significant side effects.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgiou, Elena
- Γεωργίου, Έλενα
Subjects
dc:subject × 22- Μη στεροειδή αντιφλεγμονώδη φάρμακα σαν αντικαρκινικά φάρμακα
- Αντικαρκινικά σύμπλοκα κασσιτέρου
- Αντιφλεγμονώδη σύμπλοκα κασσιτέρου
- Μεταλλικά σύμπλοκα με μη στεροειδή αντιφλεγμονώδη φάρμακα σαν υποκαταστάτες
- Αναστολείς των ενζύμων XOX-1, COX-2, LOX
- Αναστολή αιμοπεταλιακής συσσώρευσης μέσω μεταλλικών συμπλόκων
- Αντίδραση μεταλλικών συμπλόκων με αντιοξειδωτικά
- Τροποποίηση της κυτταροτοξικότητας μεταλλικών συμπλόκων με αντιοξειδωτικά
- Nonsteroidal anti-inflammatory drugs as anticancer drugs
- Tin complexes as anticancer agents
- Tin complexes as antiinflammatory agents
- Metal complexes with NSAIDs as ligands
- Inhibitors of the enzyme COX-1, COX-2, LOX
- Inhibition of platelet aggregation by metal complexes
- Reaction of metal complexes with antioxidants
- Modification of the cytotoxicity of metal complexes with antioxidants
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29023